Oramed Pharmaceuticals
ORMP
ORMP
56 hedge funds and large institutions have $5.99M invested in Oramed Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.
Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
12
Reduced
13
Closed
6
Calls
$158K
Puts
$75K
Net Calls
+$83K
Net Calls Change
-$367K
Top Buyers
1 |
RG
1
Rathbones Group
Liverpool,
United Kingdom
|
$756K |
2 |
2
Goldman Sachs
New York
|
$401K |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$71.2K |
4 |
4
LPL Financial
San Diego,
California
|
$97.1K |
5 |
5
Squarepoint
New York
|
$138K |